Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore what a balanced crypto portfolio looks like to understand successful investment strategies. Visualize your future gains.
25,379 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
As we enter June, investors wonder if summer headwinds are already priced into stocks. This article breaks down prici...
In 2026, the tech world expects IT spending to top the trillion-dollar mark, led by AI, cloud, and data-center expans...
A blockbuster TSMC update is reshaping the AI chip market. Here are three stocks I’m buying after Taiwan’s announceme...
When a Cheesecake Factory executive moved nearly 4,800 shares, it stirred questions about CAKE stock. This guide brea...
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
Apple may be eyeing a breakthrough to reduce on-device memory needs, a move that could shake Micron and the broader m...
When the market pulls back, the smartest move isn’t panic selling. This guide reveals the best stocks after this sell...
BNB Chain invites builders, investors, and institutional leaders to a day of demos and expert panels at PAMM during C...
Bitcoin rose above $60,000, yet a large inflow of BTC to exchanges suggests the rebound could face renewed selling pr...
I once believed SpaceX would be a slam-dunk winner for investors. Then I realized a careful, staged approach beats ri...
Insider trades can offer clues about a company’s near-term path. This article digs into a Mineralys insider banked $5...